Immune thrombocytopenic purpura
ICD-10 D69.3 is a billable code used to indicate a diagnosis of immune thrombocytopenic purpura.
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a significant reduction in platelet count, leading to an increased risk of bleeding. The condition arises when the immune system mistakenly targets and destroys platelets, which are essential for normal blood clotting. Patients with ITP may present with symptoms such as easy bruising, petechiae, and prolonged bleeding from minor cuts. The diagnosis is typically made through a combination of clinical evaluation and laboratory tests, including complete blood counts and bone marrow examination to rule out other causes of thrombocytopenia. ITP can be classified into primary (idiopathic) and secondary forms, with the latter often associated with underlying conditions such as infections, autoimmune diseases, or certain medications. Treatment options vary based on the severity of the condition and may include corticosteroids, immunoglobulins, or splenectomy in refractory cases. Understanding the pathophysiology of ITP is crucial for effective management and coding, as it directly impacts the patient's risk for bleeding and the need for potential interventions.
Detailed history of bleeding episodes, platelet counts, and treatment responses.
Patients presenting with unexplained bruising, recurrent nosebleeds, or prolonged bleeding after minor procedures.
Documentation must clearly indicate the autoimmune nature of ITP and any associated conditions.
Comprehensive patient history and physical examination findings related to bleeding symptoms.
Initial evaluation of patients with low platelet counts and referral to hematology for further management.
Primary care providers should document any referrals and follow-up care related to ITP.
Used to monitor platelet levels in patients diagnosed with ITP.
Document the reason for the CBC and any relevant clinical findings.
Hematologists may require more frequent monitoring compared to primary care.
ITP is primarily caused by an autoimmune response where the immune system mistakenly attacks and destroys platelets, leading to thrombocytopenia.
